These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3943923)

  • 1. Immunological consequences of tumor excision: from active immunity to immunological memory.
    Bursuker I; North RJ
    Int J Cancer; 1986 Feb; 37(2):275-81. PubMed ID: 3943923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of generation of concomitant antitumor immunity by passively transferred suppressor T cells from tumor-bearing donors.
    Bursuker I; North RJ
    Cancer Immunol Immunother; 1985; 19(3):215-8. PubMed ID: 3159472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity.
    Bursuker I; North RJ
    J Exp Med; 1984 May; 159(5):1312-21. PubMed ID: 6232336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cyclophosphamide on immunity against chemically-induced syngeneic murine sarcomas.
    Steele G; Pierce GE
    Int J Cancer; 1974 Apr; 13(4):572-8. PubMed ID: 4842326
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of interferon-gamma by in vivo tumor-sensitized T cells: association with active antitumor immunity.
    Bursuker I; Pearce MT
    J Interferon Res; 1990 Feb; 10(1):1-11. PubMed ID: 2109780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents.
    Ebina T; Murata K
    Jpn J Cancer Res; 1992 Jul; 83(7):775-82. PubMed ID: 1517151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.
    North RJ; Bursuker I
    J Exp Med; 1984 May; 159(5):1295-311. PubMed ID: 6232335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
    Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
    Flood PM
    J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the phenotypes of cells mediating anti-tumour immunity at various stages of tumour progression in mice.
    Dent LA; Spencer LK; Attridge S; Finlay-Jones JJ
    Immunol Cell Biol; 1989 Dec; 67 ( Pt 6)():403-12. PubMed ID: 2696727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity.
    DiGiacomo A; North RJ
    J Exp Med; 1986 Oct; 164(4):1179-92. PubMed ID: 2944983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antitumor immunity by tumor cells treated with abrin.
    Shionoya H; Arai H; Koyanagi N; Ohtake S; Kobayashi H; Kodama T; Kato H; Tung TC; Lin JY
    Cancer Res; 1982 Jul; 42(7):2872-6. PubMed ID: 7083176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of PSK: role of regional lymph nodes and enhancement of concomitant and sinecomitant immunity in the mouse.
    Ebina T; Kohya H; Ishikawa K
    Jpn J Cancer Res; 1989 Feb; 80(2):158-66. PubMed ID: 2498250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological role of vitamin A and its related substances in prevention of cancer.
    Tomita Y
    Nutr Cancer; 1983; 5(3-4):187-94. PubMed ID: 6669479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.
    North RJ
    J Exp Med; 1982 Apr; 155(4):1063-74. PubMed ID: 6460831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.
    Smyth MJ; Crowe NY; Godfrey DI
    Int Immunol; 2001 Apr; 13(4):459-63. PubMed ID: 11282985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro detection of cell-mediated immunity to individual tumor-specific antigens of chemically induced BALB/c fibrosarcomas.
    Carbone G; Colombo MP; Sensi ML; Cernuschi A; Parmiani G
    Int J Cancer; 1983 Apr; 31(4):483-9. PubMed ID: 6832855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
    Brannen GE; Adams JS; Santos GW
    J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of protective immunity against bacterial and viral infections in tumor-bearing mice coincident with suppression of tumor immunity.
    Bonventre PF; Nickol AD; Ball EJ; Michael JG; Bubel HC
    J Reticuloendothel Soc; 1982 Jul; 32(1):25-35. PubMed ID: 6290658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.